LKFT vs TRAX: stock comparison and AI forecast
Lakefront Biotherapeutics Nv (LKFT) and First Tracks Biotherapeutics, Inc. (TRAX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
LKFT Lakefront Biotherapeutics Nv
- Price
- $33.56 +21.0% · 6M
- Market Cap
- $2.21B
- P/E Ratio
- 5.0x
- Size
- mid-cap
- AI Forecast
TRAX First Tracks Biotherapeutics, Inc.
- Price
- $45.43 -1.5% · 6M
- Market Cap
- $1.91B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- LKFT is 1.2 times larger than TRAX by market capitalization ($2.21B against $1.91B).
- Over the last six months LKFT returned +21.0% and TRAX -1.5%.
- TRAX carries 0.13 times debt per unit of equity, against 0.05 times for LKFT.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | LKFT | TRAX |
|---|---|---|
| Market Cap | $2.21B | $1.91B |
| P/E Ratio | 5.04x | – |
| P/B Ratio | – | 12.65x |
| EPS | $6.66 | – |
| Book Value/Share | – | $3.59 |
| Revenue/Share | $36.68 | – |
| FCF/Share | $-26.83 | – |
Profitability & Margins
| Metric | LKFT | TRAX |
|---|---|---|
| ROE | 12.0% | – |
| ROA | 11.4% | – |
| ROIC | -7.7% | – |
| Gross Margin | 96.3% | – |
| Operating Margin | -11.7% | – |
| Net Margin | 18.2% | – |
| EBT Margin | 4.1% | – |
| Tax Rate | -9.0% | – |
Financial Health
| Metric | LKFT | TRAX |
|---|---|---|
| Current Ratio | 20.15x | 9.16x |
| Quick Ratio | 20.00x | – |
| D/E Ratio | 0.05x | 0.13x |
| Financial Leverage | 1.05x | 1.13x |
| Working Capital | $3.44B | $148M |
Cash Flow
| Metric | LKFT | TRAX |
|---|---|---|
| Operating Cash Flow | -$1.68B | – |
| Free Cash Flow | -$1.77B | – |
| Capital Spending | -$87M | – |
| FCF/Sales | -73.2% | – |
| CapEx/Sales | 3.6% | – |
Operational Efficiency
| Metric | LKFT | TRAX |
|---|---|---|
| Asset Turnover | 0.63x | – |
| Receivables Turnover | 103.0x | – |
| Inventory Turnover | 3.5x | – |
| Fixed Assets Turnover | 29.6x | – |
| Days Sales Outstanding | 4 days | – |
| Days Inventory | 105 days | – |
| Payables Period | 488 days | – |
| Cash Conversion Cycle | -379 days | – |
Income Statement
| Metric | LKFT | TRAX |
|---|---|---|
| Total Revenue | $2.42B | – |
| Operating Income | -$282M | – |
| Net Income | $440M | – |
| R&D Expense | $1.76B | – |
| Cost of Goods Sold | $89M | – |
Dividend & Shareholder Information
| Metric | LKFT | TRAX |
|---|---|---|
| Shares Outstanding | 66M | 42M |
LKFT vs TRAX: stock comparison and AI forecast
Which is bigger, LKFT or TRAX?
LKFT is 1.2 times larger than TRAX by market capitalization ($2.21B against $1.91B).
Which stock performed better over the last six months, LKFT or TRAX?
Over the last six months LKFT returned +21.0% and TRAX -1.5%.
Which one does Intratio's AI model rank higher, LKFT or TRAX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.